AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a read more
Edward Myles MBA ā Executive VP & CFO at AMAG Pharmaceuticals
Executive Bio
Mr. Edward H. Myles, also known as Ted, MBA, has been the Chief Financial Officer at AMAG Pharmaceuticals, Inc. since April 2016, has been its Executive Vice President since December 12, 2017 and served as its Senior Vice President and Treasurer until December 12, 2017. Mr. Myles served as Senior Vice President of Finance at AMAG Pharmaceuticals, Inc. Mr. Myles served as Chief Financial Officer at Ocata Therapeutics, Inc. (also known as Advanced Cell Technology Inc.) from June 12, 2013 to February 10, 2016 and its Chief Operating Officer since May 2014 to February 10, 2016. Mr. Myles served as the Executive Vice President of Corporate Development at Advanced Cell Technology Inc., since June 12, 2013. Mr. Myles served as the Principal Executive Officer of Advanced Cell Technology Inc. until June 24, 2014 and served as its Interim President since January 22, 2014 until June 24, 2014. Mr. Myles served as the Chief Financial Officer and Vice President of Operations at PrimeraDx, Inc., until June 2013. He joined PrimeraDx in 2008. Mr. Myles served as the Chief Financial Officer of Pressure BioSciences, Inc. from April 3, 2006 to November 18, 2008, Vice President of Finance since April 3, 2006, Senior Vice President, Finance from February 12, 2007 to November 18, 2008 and also served as its Treasurer. He served as a Consultant of Pressure BioSciences, Inc. He served as Controller of EMD Pharmaceuticals, a wholly-owned affiliate of Merck KGaA from 2003 to 2006. Mr. Myles held a wide variety of responsibilities in the areas of accounting, licensing & business development at EMD. Mr. Myles worked for the health care investment banking group of SG Cowen Securities Corporation from 2002 to 2003, where he provided advisory services to emerging and middle-market companies. He co-founded Luminomics, an early-stage biotechnologycompany. Mr. Myles served as Corporate Controller of Boston Biomedica, Inc., where he oversaw all financial reporting, accounting and financial operations. He joined Boston Biomedica, Inc. in 1997. Mr. Myles worked at the accounting firms Price Waterhouse LLP and Coopers & Lybrand LLP, where he held positions of increasing responsibility from 1993 to 1997. Mr. Myles has been a Certified Public Accountant since 1996. He holds a BSBA in Accounting and Finance from the University of Hartford and MBA with an emphasis on strategy and corporate finance from Washington University in St. Louis.
Executive VP & CFO Impact on Finance Department's Culture
Edward Myles MBA holds the highest position within the Finance department at AMAG Pharmaceuticals ā Executive VP & CFO, and therefore has influence on the culture of the Finance department.
Are you challenged at work?
Are your company's goals clear, and are you invested in them?
Are you satisfied with your work/life balance?
Is your work environment positive or negative?
How would you rate the value & quality of meetings at your company?
Does your current company provide you meaningful opportunities for career advancement?
Executive Team Culture Ratings from AMAG Pharmaceuticals Employees
BOTTOM
40%
AMAG Pharmaceuticals' Executive Team scores in the Bottom 40%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at AMAG PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at AMAG PharmaceuticalsAMAG Pharmaceuticals' Executive Team at a Glance
Based on 4 ratings, AMAG Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āCā or 64/100.
AMAG Pharmaceuticals' Executive Team ranks in the Bottom 35% of other companies in Boston and Bottom 40% of other companies on Comparably that also have 201-500 Employees.
×